10 Hot Stocks to Watch — Friday, October 16, 2026

Coinbase surged 6.32% to $183.81, breaking a downward trend that saw shares fall 24% year-to-date amid weak trading volumes and earnings headwinds. The options market is signaling conviction: call-to-put ratio hit 2.44, with aggressive positioning in $185 and $192.50 calls expiring October 2026, each seeing 15,500+ contracts flow through. Citi's recent price-target hike on crypto equities and SEC approval of KPI-linked derivatives are rekindling appetite for exchange-listed crypto exposure. Watch $192.50 as near-term resistance.

ServiceNow climbed 6.14% today after unveiling EmployeeWorks, a next-generation AI platform enabling non-technical workers to build custom agents without coding—a move that also quashed acquisition speculation and sparked fresh price-target upgrades. Options flow shows mixed conviction: call volume dominates with 13,806 contracts across strikes, but the $150 calls expiring tomorrow trade near resistance, suggesting traders are locking in gains rather than pushing higher. The $137 put volume (3,609) signals some downside hedging; watch $150 as the critical near-term technical level.

MicroStrategy fell 5.87% today as potential MSCI index removal looms, threatening forced selling pressure despite CEO Michael Saylor's bullish $100K Bitcoin calls. Options flow tells a different story: call volume exploded across $157.50–$165 strikes (expiring October 2026), with a 5.67 call-to-put ratio signaling heavy institutional conviction. The divergence between headline risk and derivatives positioning suggests traders are hedging near-term volatility while betting on crypto's generational supercycle thesis—though with 3.6x beta, any crypto pullback could prove painful.

Salesforce surged 4.6% to $246.74 as investors cheered the October rollout of Hunter, its AI-powered outbound sales agent built on Agentforce, featuring deep integrations with ZoomInfo, Demandbase, and Docusign. The options market is pricing in further upside: call-to-put ratio stands at 1.77 with heavy activity in $250 and $260 calls expiring today, signaling traders expect the momentum to persist through the European close. Watch the $250 strike as a key resistance level; a break above could re-test the 52-week high of $269.

Moderna surged 4.51% to $236.50 today, breaking through its 52-week high as investors rotated into healthcare ahead of melanoma vaccine data. Goldman Sachs raised its price target to $137, though that still sits below current levels—a cautionary signal amid the euphoria. Options markets are screaming bullish, with 2.86 call-to-put ratio and heavy activity in $240–$250 October 2026 calls, suggesting traders are positioning for sustained momentum into year-end. Watch $250 resistance; valuation concerns persist despite the clinical narrative.

NIO shares dropped 4.24% today to $3.39, dragged down by broad weakness in Chinese automakers facing soft domestic demand and EU hybrid tariffs. Yet options markets are flashing a contrarian signal: a 4.42 call-to-put ratio and heavy call buying around the $3.50 strike through late October suggest traders see a floor and near-term rebound potential. Street consensus targets $6—a 77% upside—hinging on whether NIO's September delivery refresh and battery-swapping expansion can restore investor conviction amid Tesla's resilience in China.

Applied Materials dropped sharply today following hotter-than-expected inflation data that stoked concerns elevated rates will dampen AI infrastructure spending—a key demand driver for semiconductor equipment makers. The stock has fallen 17.6% since early October, though management's $5B innovation center announcement signals confidence in long-term cycle strength. Options traders are hedging aggressively, with put volume spiking $520/$540 strikes (Oct 16), though call interest at $450 suggests some buyers view dips as entry points. Watch the $420 support level and Oct 16 expiry for near-term direction.

Eli Lilly surged 3.55% to $1,251.61 after reporting Omvoh achieved steroid-free disease control in difficult-to-treat inflammatory bowel disease, a meaningful clinical win in a competitive category. Options traders are aggressively positioned for further upside, with a 4.66 call-to-put ratio and heavy volume in $1,300–$1,360 October 2026 calls—suggesting conviction above current levels. Watch the $1,300 strike as the next technical resistance; the stock sits just 3% below that mark with six months of 25% gains already priced in.

Qualcomm rallied 3.35% to $178.40 following announcement of its first AI-native Wi-Fi 8 gateway, positioning the chipmaker at the intersection of residential broadband and edge AI—a faster-growing adjacency than smartphone markets. Options traders are aggressively bullish, with a 6.47 call-to-put ratio and 20,841 contracts traded across $180–$185 strikes expiring mid-to-late October, suggesting confidence in a breakout above $180 by Wednesday's expiry. Institutional comparisons favoring QCOM's cash generation over Intel's foundry losses add fundamental tailwinds, though near-term momentum hinges on sustaining above $182.50.

Lam Research tumbled alongside semiconductor peers after hotter-than-expected inflation data reignited concerns over elevated borrowing costs crimping AI capex. The options market is flashing red: a 0.51 call-to-put ratio reflects heavy downside hedging, with over 7,700 puts across the $320–$330 strikes expiring October 16 trading at record volume. Watch the $277 level for support; a break below opens the $250 put strike on Oct 23.